uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
This report contains market size and forecasts of Duchenne Muscular Dystrophy in US, including the following market information:
US Duchenne Muscular Dystrophy Market Revenue, 2015-2020, 2021-2026, ($ millions)
US Duchenne Muscular Dystrophy Market Consumption, 2015-2020, 2021-2026, (K Doses)
US Duchenne Muscular Dystrophy Production Capacity, 2015-2020, 2021-2026, (K Doses)
Top Five Competitors in US Duchenne Muscular Dystrophy Market 2019 (%)
The global Duchenne Muscular Dystrophy market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Duchenne Muscular Dystrophy market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Duchenne Muscular Dystrophy manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Duchenne Muscular Dystrophy production and consumption in US
Total Market by Segment:
US Duchenne Muscular Dystrophy Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Doses)
US Duchenne Muscular Dystrophy Market Segment Percentages, By Type, 2019 (%)
- Deflazacort
- Prednisone
- Others
US Duchenne Muscular Dystrophy Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Doses)
US Duchenne Muscular Dystrophy Market Segment Percentages, By Application, 2019 (%)
- Male
- Female
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Duchenne Muscular Dystrophy Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)
Total Duchenne Muscular Dystrophy Market Competitors Revenues Share in US, by Players 2019 (%)
Total US Duchenne Muscular Dystrophy Market Competitors Sales, by Players 2015-2020 (Estimated), (K Doses)
Total US Duchenne Muscular Dystrophy Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- PTC Therapeutics
- Sarepta Therapeutics
Duchenne Muscular Dystrophy Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Duchenne Muscular Dystrophy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 US Duchenne Muscular Dystrophy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 Impact: US Duchenne Muscular Dystrophy Overall Market Size
2.1 US Duchenne Muscular Dystrophy Market Size: 2020 VS 2026
2.2 US Duchenne Muscular Dystrophy Revenue, Prospects & Forecasts: 2015-2026
2.3 US Duchenne Muscular Dystrophy Sales (Consumption): 2015-2026
3 Company Landscape
3.1 Top Duchenne Muscular Dystrophy Players in US (including Foreign and Local Companies)
3.2 Top US Duchenne Muscular Dystrophy Companies Ranked by Revenue
3.3 US Duchenne Muscular Dystrophy Revenue by Companies (including Foreign and Local Companies)
3.4 US Duchenne Muscular Dystrophy Sales by Companies (including Foreign and Local Companies)
3.5 US Duchenne Muscular Dystrophy Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Duchenne Muscular Dystrophy Companies in US, by Revenue in 2019
3.7 US Manufacturers Duchenne Muscular Dystrophy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Duchenne Muscular Dystrophy Players in US
3.8.1 List of US Tier 1 Duchenne Muscular Dystrophy Companies
3.8.2 List of US Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - US Duchenne Muscular Dystrophy Market Size Markets, 2020 & 2026
4.1.2 Deflazacort
4.1.3 Prednisone
4.1.4 Others
4.2 By Type - US Duchenne Muscular Dystrophy Revenue & Forecasts
4.2.1 By Type - US Duchenne Muscular Dystrophy Revenue, 2015-2020
4.2.2 By Type - US Duchenne Muscular Dystrophy Revenue, 2021-2026
4.2.3 By Type - US Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026
4.3 By Type - US Duchenne Muscular Dystrophy Sales & Forecasts
4.3.1 By Type - US Duchenne Muscular Dystrophy Sales, 2015-2020
4.3.2 By Type - US Duchenne Muscular Dystrophy Sales, 2021-2026
4.3.3 By Type - US Duchenne Muscular Dystrophy Sales Market Share, 2015-2026
4.4 By Type - US Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - US Duchenne Muscular Dystrophy Market Size, 2020 & 2026
5.1.2 Male
5.1.3 Female
5.2 By Application - US Duchenne Muscular Dystrophy Revenue & Forecasts
5.2.1 By Application - US Duchenne Muscular Dystrophy Revenue, 2015-2020
5.2.2 By Application - US Duchenne Muscular Dystrophy Revenue, 2021-2026
5.2.3 By Application - US Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026
5.3 By Application - US Duchenne Muscular Dystrophy Sales & Forecasts
5.3.1 By Application - US Duchenne Muscular Dystrophy Sales, 2015-2020
5.3.2 By Application - US Duchenne Muscular Dystrophy Sales, 2021-2026
5.3.3 By Application - US Duchenne Muscular Dystrophy Sales Market Share, 2015-2026
5.4 By Application - US Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 PTC Therapeutics
6.1.1 PTC Therapeutics Corporate Summary
6.1.2 PTC Therapeutics Business Overview
6.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Major Product Offerings
6.1.4 PTC Therapeutics Sales and Revenue in US (2015-2020)
6.1.5 PTC Therapeutics Key News
6.2 Sarepta Therapeutics
6.2.1 Sarepta Therapeutics Corporate Summary
6.2.2 Sarepta Therapeutics Business Overview
6.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Major Product Offerings
6.2.4 Sarepta Therapeutics Sales and Revenue in US (2015-2020)
6.2.5 Sarepta Therapeutics Key News
6.3 Others
6.3.1 Others Corporate Summary
6.3.2 Others Business Overview
6.3.3 Others Duchenne Muscular Dystrophy Major Product Offerings
6.3.4 Others Sales and Revenue in US (2015-2020)
6.3.5 Others Key News
7 Duchenne Muscular Dystrophy Production Capacity, Export and Import Analysis
7.1 Duchenne Muscular Dystrophy Production Capacity and Value in US, Situation Analysis and Prediction, 2015-2026
7.1.1 US Duchenne Muscular Dystrophy Production Capacity, 2015-2026
7.1.2 US Duchenne Muscular Dystrophy Production 2015-2026
7.1.3 US Duchenne Muscular Dystrophy Production Value 2015-2026
7.2 Key Local Duchenne Muscular Dystrophy Manufacturers in US
7.2.1 US Key Local Duchenne Muscular Dystrophy Manufacturers Production Capacity
7.2.2 US Key Local Duchenne Muscular Dystrophy Manufacturers Production
7.2.3 US Key Local Duchenne Muscular Dystrophy Manufacturers Production Value
7.2.4 The Proportion of Duchenne Muscular Dystrophy Production Sold in US and Sold Other Than US by Manufacturers
7.3 Duchenne Muscular Dystrophy Export and Import in US
7.3.1 US Duchenne Muscular Dystrophy Export Market
7.3.2 US Duchenne Muscular Dystrophy Source of Imports
8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for US Duchenne Muscular Dystrophy Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 Impact on Duchenne Muscular Dystrophy Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Duchenne Muscular Dystrophy Distributors and Sales Agents in US
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
List of Tables
Table 1. Key Players of Duchenne Muscular Dystrophy in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Duchenne Muscular Dystrophy Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Duchenne Muscular Dystrophy Revenue Share by Companies, 2015-2020
Table 5. US Duchenne Muscular Dystrophy Sales by Companies, (K Doses), 2015-2020
Table 6. US Duchenne Muscular Dystrophy Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Duchenne Muscular Dystrophy Price (2015-2020) (USD/Dose)
Table 8. US Manufacturers Duchenne Muscular Dystrophy Product Type
Table 9. List of US Tier 1 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Duchenne Muscular Dystrophy Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Duchenne Muscular Dystrophy Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Duchenne Muscular Dystrophy Sales in US (K Doses), 2015-2020
Table 14. By Type - Duchenne Muscular Dystrophy Sales in US (K Doses), 2021-2026
Table 15. By Application - Duchenne Muscular Dystrophy Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Duchenne Muscular Dystrophy Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Duchenne Muscular Dystrophy Sales in US, (K Doses), 2015-2020
Table 18. By Application - Duchenne Muscular Dystrophy Sales in US, (K Doses), 2021-2026
Table 19. PTC Therapeutics Corporate Summary
Table 20. PTC Therapeutics Duchenne Muscular Dystrophy Product Offerings
Table 21. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 22. Sarepta Therapeutics Corporate Summary
Table 23. Sarepta Therapeutics Duchenne Muscular Dystrophy Product Offerings
Table 24. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 25. Others Corporate Summary
Table 26. Others Duchenne Muscular Dystrophy Product Offerings
Table 27. Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 28. Duchenne Muscular Dystrophy Production Capacity (K Doses) of Local Manufacturers in US, 2015-2020
Table 29. Duchenne Muscular Dystrophy Production (K Doses) of Local Manufacturers in US, 2015-2020
Table 30. US Duchenne Muscular Dystrophy Production Market Share of Local Manufacturers, 2015-2020
Table 31. Duchenne Muscular Dystrophy Production Value (US$, Mn) of Local Manufacturers in US, 2015-2020
Table 32. US Duchenne Muscular Dystrophy Production Value Market Share of Local Manufacturers, 2015-2020
Table 33. The Percentage of Duchenne Muscular Dystrophy Production Sold in US and Sold Other Than US by Manufacturers
Table 34. The Percentage of Duchenne Muscular Dystrophy Production Sold in US and Sold Other Than US by Manufacturers
Table 35. Dangeguojia Duchenne Muscular Dystrophy Sales (Consumption), Production, Export and Import, 2015-2020
Table 36. Raw Materials and Suppliers
Table 37. Duchenne Muscular Dystrophy Downstream Clients in US
Table 38. Duchenne Muscular Dystrophy Distributors and Sales Agents in US
List of Figures
Figure 1. Duchenne Muscular Dystrophy Segment by Type
Figure 2. Duchenne Muscular Dystrophy Segment by Application
Figure 3. Dangeguojia Duchenne Muscular Dystrophy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Duchenne Muscular Dystrophy Market Size in US, (US$, Mn) & (K Doses): 2020 VS 2026
Figure 6. US Duchenne Muscular Dystrophy Revenue, 2015-2026 (US$, Mn)
Figure 7. Duchenne Muscular Dystrophy Sales in US: 2015-2026 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Duchenne Muscular Dystrophy Revenue in 2019
Figure 9. By Type - US Duchenne Muscular Dystrophy Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - US Duchenne Muscular Dystrophy Market Share, 2015-2020
Figure 11. By Type - US Duchenne Muscular Dystrophy Market Share, 2020-2026
Figure 12. By Type - US Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026
Figure 13. By Application - Duchenne Muscular Dystrophy Revenue in US (US$, Mn), 2020 & 2026
Figure 14. By Application - US Duchenne Muscular Dystrophy Market Share, 2015-2020
Figure 15. By Application - US Duchenne Muscular Dystrophy Market Share, 2020-2026
Figure 16. By Application -US Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026
Figure 17. US Duchenne Muscular Dystrophy Production Capacity (K Doses), 2015-2026
Figure 18. US Duchenne Muscular Dystrophy Actual Output (K Doses), 2015-2026
Figure 19. US Duchenne Muscular Dystrophy Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of US Duchenne Muscular Dystrophy Export Destination, 2019
Figure 21. The Source of Imports of US Duchenne Muscular Dystrophy, 2019
Figure 22. PEST Analysis for US Duchenne Muscular Dystrophy Market in 2020
Figure 23. Duchenne Muscular Dystrophy Market Opportunities & Trends in US
Figure 24. Duchenne Muscular Dystrophy Market Drivers in US
Figure 25. Duchenne Muscular Dystrophy Market Restraints in US
Figure 26. Duchenne Muscular Dystrophy Industry Value Chain
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
